Protagonist Therapeutics PTGX 深 沪
等待开盘 10-18 09:30:00 美东时间
47.02
+0.030
+0.06%
华盛通- 最 高47.535
- 今 开47.11
- 成交量 55.45万股
- 最 低 46.68
- 昨 收 46.99
- 总市值 27.05亿
- 52周最高 48.3225
- 市盈率 静 --
- 换手率 0.96%
- 52周最低 13.72
- 委 比 33.33%
- 总股本 5753.02万
- 历史最高 50.54
- 量 比 0.89
- 振 幅 1.82%
- 历史最低 4.47
- 每 手 1
- 风险率 8.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Capitulation in biotech is near, as well as a rally – Piper Sandler
Big amounts of selling in the healthcare-biotech sectors (NYSEARCA:XBI) could be signaling capitulation, followed by a rally, according to Piper Sandler. Capitulation is an extreme panic signal after ...
10-11 23:17
快讯 | Protagonist Therapeutics Inc：特许金融发起覆盖，并给予买入评级；目标价65美元
Protagonist Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating; Tar...
09-24 17:46
Protagonist Therapeutics Board and Audit Committee Changes
An update from Protagonist Therapeutics ( ($PTGX) ) is now available. Daniel N....
09-21 04:29
快讯 | Protagonist Therapeutics, Inc.：H.C. Wainwright将目标价从38美元上调至40美元
Protagonist Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $40 Fro...
08-07 18:10
Protagonist Therapeutics Q2 2024 GAAP EPS $(0.50) Beats $(0.69) Estimate
Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.69) by 27.54 percent. This is a 26.47 percent increase over losses of $(0.68) per
08-06 19:52
Protagonist Therapeutics shares are trading lower. The company reported Q2 financial results.
Protagonist Therapeutics shares are trading lower. The company reported Q2 fina...
08-06 19:50
快讯 | protagonist therapeutics第二季度基本每股收益为美元指数-0.5
Protagonist Therapeutics Q2 Basic EPS USD -0.5
08-06 19:02
快讯 | Protagonist Therapeutics第二季度净利润为-3061.6万美元，IBES预估为-3680万美元。
Protagonist Therapeutics Q2 Net Income USD -30.616 Million Vs. IBES Estimate US...
08-06 19:02
美股牛股 | 咨询方案提供商QXO涨超56.3%；新股OneStream首日收涨34.2%
咨询方案提供商QXO涨超56.3%，近日宣布了一项定向增发融资；新股OneStream首日收涨34.2%>>
07-25 19:41
快讯 | Protagonist Therapeutics Inc: JP Morgan将目标价从39美元上调至48美元
Protagonist Therapeutics Inc : JP Morgan Raises Target Price to $48 From $39
07-25 12:28
